This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hepatomegaly and splenomegaly, not elsewhere classified
R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
423 |
4. Check minimum number of eventsNone |
423 |
5. Include endpointsNone |
423 |
6. Filter based on genotype QC (FinnGen only) |
363 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_DIGES_SYSTEM_ABDOMEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R1
- Name in latin
- Hepatomegalia et/sive splenomegalia non alibi classificata
Similar endpoints
↥List of similar endpoints to
Hepatomegaly and splenomegaly, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the digestive system and abdomen
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 363 | 166 | 197 |
| Unadjusted period prevalence (%) | 0.08 | 0.06 | 0.09 |
| Median age at first event (years) | 53.70 | 49.27 | 57.44 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 379
- Matched controls
- 3790
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
10561.9
307.7
265
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
12.6
137.8
191
282
XW000
NOMESCO Finland
Bone marrow biopsy
18.9
109.7
95
66
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
10.2
101.5
147
221
R16.0
ICD-10 Finland
Hepatomegaly, not elsewhere classified
+∞
89.2
82
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
7.6
86.9
193
456
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
11.3
67.3
78
85
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.6
63.9
85
111
R16.2
ICD-10 Finland
Hepatomegaly with splenomegaly, not elsewhere classified
544.6
49.6
48
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
19.4
46.1
37
21
JN4BD
NOMESCO Finland
Extensive body CT
6.1
42.0
85
172
R50.9
ICD-10 Finland
Fever, unspecified
5.0
41.2
111
289
UJF32
NOMESCO Finland
Coloscopy
4.4
40.0
140
446
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
37.4
242
1167
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
14.8
37.0
34
25
D73.1
ICD-10 Finland
Hypersplenism
+∞
34.9
33
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.7
34.7
60
103
R10.1
ICD-10 Finland
Pain localized to upper abdomen
5.2
33.2
79
183
D64.9
ICD-10 Finland
Anaemia, unspecified
4.9
30.7
77
186
R11
ICD-10 Finland
Nausea and vomiting
8.2
29.9
42
57
ZX120
NOMESCO Finland
Intravenous
5.0
28.0
68
159
C03DA01
ATC
spironolactone; oral
4.6
28.0
78
204
WW500
NOMESCO Finland
Blood transfusion
7.1
27.1
43
67
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
26.7
70
174
JMA10
NOMESCO Finland
Transabdominal total splenectomy
64.9
26.4
30
5
H02AB06
ATC
prednisolone; systemic
3.0
24.1
213
1140
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
9.4
22.7
28
32
J01MA12
ATC
levofloxacin; systemic
3.5
22.7
96
335
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
55.6
22.4
26
5
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
85.3
21.9
24
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
21.8
127
536
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.8
21.6
53
124
UJF30
NOMESCO Finland
Ileoscopy through colon
4.3
20.9
60
159
C03CA01
ATC
furosemide; systemic
3.0
20.9
133
587
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
19.7
20.8
31
17
JN3AD
NOMESCO Finland
Abdominal CT examination
4.1
20.5
62
171
JN4AD
NOMESCO Finland
Body CT examination
3.7
19.9
71
220
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.7
19.9
74
236
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
6.8
19.6
32
51
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.9
19.5
31
48
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
8.4
19.4
26
33
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
20.0
18.9
28
15
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
40.7
18.8
23
6
R18
ICD-10 Finland
Ascites
199.5
18.7
19
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
7.7
18.0
26
36
M04AA01
ATC
allopurinol; systemic
3.4
17.8
74
253
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
17.7
90
347
A02BC02
ATC
pantoprazole; systemic
2.7
17.5
268
1786
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.3
17.2
26
38
R06.0
ICD-10 Finland
Dyspnoea
2.7
17.1
123
570
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.1
16.8
26
39
A10AE04
ATC
insulin glargine; parenteral
3.6
16.8
63
201
A06AD11
ATC
lactulose; oral
3.4
16.6
69
235
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
15.7
15
*
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
+∞
15.7
15
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
15.5
175
996
A10AC01
ATC
insulin (human); parenteral
3.8
15.1
49
141
N03AX16
ATC
[U] pregabalin
2.8
15.0
94
403
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
15.0
58
188
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.6
14.7
37
88
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
83.4
14.7
16
*
A02BC01
ATC
omeprazole; systemic
2.6
14.5
109
511
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
14.5
39
98
J01MA02
ATC
ciprofloxacin; systemic
2.4
14.4
151
826
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
24.9
13.9
19
8
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
12.7
13.8
24
20
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
13.5
73
288
JAH01
NOMESCO Finland
Laparoscopy
6.0
13.4
24
42
WZC00
NOMESCO Finland
Treatment plan or consultation
2.3
13.4
157
895
127
Kela drug reimbursment
Transplant complication
15.8
13.2
21
14
UJF92
NOMESCO Finland
Capsular endoscopy
11.6
13.2
24
22
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
3.8
13.1
43
125
A10AB05
ATC
insulin aspart; parenteral
3.5
12.9
47
146
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
12.8
56
196
103
Kela drug reimbursment
Diabetes, insulin-treated
2.4
12.7
122
636
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
72.3
12.7
14
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
12.6
84
369
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
12.6
96
450
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
12.5
109
544
JN4CD
NOMESCO Finland
Very extensive body CT
5.6
12.5
24
45
WW200
NOMESCO Finland
Immunization
6.1
12.4
22
38
D01
ICPC
Abdominal pain/cramps general
3.3
12.2
49
162
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
3.5
12.1
44
137
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.0
12.0
60
226
J01FF01
ATC
clindamycin; systemic
2.4
12.0
111
567
Z94.4
ICD-10 Finland
Liver transplant status
48.3
12.0
14
*
N02AA05
ATC
oxycodone; systemic
2.7
11.8
70
289
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
11.8
125
676
K76.9
ICD-10 Finland
Liver disease, unspecified
17.1
11.8
18
11
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
11.7
91
430
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
11.7
113
588
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
11.5
52
185
JJC00
NOMESCO Finland
Allogenic transplantation of liver
123.6
11.5
12
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
11.5
46
152
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.8
11.5
36
101
SPAT1255
SPAT
Intravenous administration of medicine
4.1
11.5
33
87
A07AA02
ATC
nystatin; oral
4.6
11.4
28
65
Z3231
NOMESCO Finland
Registered nurse
2.3
11.3
117
625
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
20.8
11.2
16
8
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.0
11.2
55
205
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
11.2
81
369
P01AB01
ATC
metronidazole; oral, rectal
2.1
11.0
146
860
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.3
11.0
43
140
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
10.9
106
551
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
10.9
37
110
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
10.7
85
404
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.6
10.6
21
23
UJD02
NOMESCO Finland
Gastroscopy
4.7
10.6
25
56
WX892
NOMESCO Finland
Monitored bed care
3.4
10.6
40
127
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
33.5
10.4
13
*
C07AB07
ATC
bisoprolol; oral
2.0
10.4
183
1191
L03AA02
ATC
filgrastim; parenteral
4.9
10.4
23
49
XF600
NOMESCO Finland
Bloodpressure measurement
3.5
10.3
36
109
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
10.3
52
197
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
10.2
28
71
N06AX21
ATC
duloxetine; oral
3.1
10.2
44
152
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.9
10.2
31
85
ZXD05
NOMESCO Finland
Urgent procedure
2.2
10.1
116
642
A02BC05
ATC
esomeprazole; systemic
2.1
10.1
141
841
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
10.1
56
223
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
10.0
72
327
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.9
9.9
22
47
J01MA14
ATC
moxifloxacin; systemic
3.2
9.9
42
144
D70.89
ICD-10 Finland
Neutropenic splenomegaly
11.8
9.7
17
15
Z2221
NOMESCO Finland
Medical doctor
2.1
9.7
113
629
L04AA06
ATC
mycophenolic acid; systemic
10.4
9.6
18
18
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
9.5
32
94
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.2
9.5
26
66
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
102.5
9.5
10
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
30.9
9.5
12
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
30.9
9.5
12
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
9.4
51
200
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.7
9.4
22
49
WX002
NOMESCO Finland
Sedation and analgesia
2.4
9.3
76
364
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
9.3
283
2202
M54.5
ICD-10 Finland
Low back pain
2.0
9.2
139
847
AA1AD
NOMESCO Finland
CT of head and brain
2.1
9.2
109
608
TK800
NOMESCO Finland
Hemodialysis
8.6
9.2
19
23
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.0
9.1
26
68
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
16.1
9.1
14
9
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
37.7
9.1
11
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
9.0
84
425
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
9.0
31
93
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
24.7
9.0
12
5
A10BA02
ATC
metformin; oral
2.0
8.9
119
694
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
9.8
8.9
17
18
L04AX01
ATC
azathioprine; systemic
4.0
8.7
25
66
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
8.6
45
173
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
28.2
8.5
11
*
ZXE00
NOMESCO Finland
One hour or less
1.9
8.5
152
978
D73.9
ICD-10 Finland
Disease of spleen, unspecified
92.0
8.4
9
*
L04AD01
ATC
ciclosporin; systemic
8.8
8.4
17
20
A03
ICPC
Fever
2.3
8.4
76
380
K74.0
ICD-10 Finland
Hepatic fibrosis
+∞
8.4
8
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
8.2
114
670
D11
ICPC
Diarrhoea
2.6
8.2
49
202
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
8.2
97
538
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
8.2
201
1426
B01AB05
ATC
enoxaparin; parenteral
2.0
8.2
114
671
A02BC03
ATC
lansoprazole; oral
2.1
8.2
96
531
D06
ICPC
Abdominal pain localized other
3.3
8.2
31
99
H02AB09
ATC
hydrocortisone; systemic
6.5
8.1
20
32
E66.8
ICD-10 Finland
Other obesity
3.7
8.1
26
74
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
34.1
8.1
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
8.1
32
105
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
8.0
166
1115
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.1
7.9
34
117
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.6
7.8
19
30
Z2446
NOMESCO Finland
Social worker
2.9
7.8
37
135
T90
ICPC
Diabetes non-insulin dependent
2.0
7.8
100
571
L04AD02
ATC
tacrolimus; systemic
15.4
7.8
12
8
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
15.4
7.8
12
8
A05AA02
ATC
ursodeoxycholic acid; oral
7.7
7.8
17
23
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
45.9
7.7
9
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.7
7.7
18
40
K92.1
ICD-10 Finland
Melaena
3.6
7.7
25
72
A99
ICPC
Disease/condition unspecnature/site
2.7
7.7
44
178
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
7.7
93
520
N06AX16
ATC
venlafaxine; oral
2.5
7.6
53
235
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
18.8
7.6
11
6
I81
ICD-10 Finland
Portal vein thrombosis
25.6
7.6
10
*
N06AA09
ATC
amitriptyline; systemic
3.0
7.6
35
126
R03AC02
ATC
salbutamol; inhalant
1.8
7.5
206
1499
Z3226
NOMESCO Finland
Physiotherapist
2.1
7.5
77
404
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.1
7.5
76
397
K72.1
ICD-10 Finland
Chronic hepatic failure
81.6
7.4
8
*
174
Kela drug reimbursment
Ruxolitinib
81.6
7.4
8
*
374
Kela drug reimbursment
Ruxolitinib
81.6
7.4
8
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
7.4
117
715
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.2
7.4
20
50
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.8
7.4
23
64
K59.09
ICD-10 Finland
Constipation, unspecified
3.4
7.4
27
84
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.5
7.4
26
79
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.5
7.4
25
74
B03XA02
ATC
darbepoetin alfa; parenteral
7.1
7.4
17
25
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.3
7.4
19
46
N05CF01
ATC
zopiclone; oral
1.9
7.3
110
662
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
7.3
70
357
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
7.3
70
357
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
16.1
7.3
11
7
K92.0
ICD-10 Finland
Haematemesis
7.5
7.3
16
22
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.6
7.2
17
38
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.4
7.2
26
80
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.2
7.2
15
19
R03BB04
ATC
tiotropium bromide; inhalant
2.6
7.1
42
172
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.5
7.1
25
76
SPAT1254
SPAT
Administration of medicine
2.4
7.1
54
250
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
6.9
18
44
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
6.9
128
823
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.4
6.8
24
73
H02AB04
ATC
methylprednisolone; systemic
2.3
6.8
52
241
R15
ICD-10 Finland
Faecal incontinence
17.1
6.8
10
6
N06AX11
ATC
mirtazapine; oral
1.9
6.7
115
719
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
6.7
104
630
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
23.0
6.7
9
*
K29.8
ICD-10 Finland
Duodenitis
23.0
6.7
9
*
WVA20
NOMESCO Finland
Medicine administration
4.1
6.7
18
45
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
6.7
39
159
A04AA01
ATC
ondansetron; systemic, rectal
2.8
6.7
34
129
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
6.7
31
112
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
6.6
27
90
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.0
6.6
29
101
R10.0
ICD-10 Finland
Acute abdomen
12.5
6.6
11
9
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
6.6
202
1497
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
6.6
53
251
D45
ICD-10 Finland
Polycythaemia vera
10.3
6.6
12
12
R60.9
ICD-10 Finland
Oedema, unspecified
3.3
6.6
25
80
C05AA08
ATC
fluocortolone; rectal, topical
2.4
6.5
49
225
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
6.5
49
225
WZC30
NOMESCO Finland
Teaching
2.1
6.5
66
343
A07EA06
ATC
budesonide; oral, local oral
3.6
6.5
21
60
SPAT1262
SPAT
Handing over of treatment supplies
2.1
6.5
67
351
R51.80
ICD-10 Finland
Headache
2.2
6.5
59
294
L01XX05
ATC
hydroxycarbamide; oral
7.6
6.5
14
19
A03FA02
ATC
cisapride; oral, rectal
3.0
6.5
28
97
D73.5
ICD-10 Finland
Infarction of spleen
71.0
6.4
7
*
L01EJ01
ATC
ruxolitinib; oral
71.0
6.4
7
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
71.0
6.4
7
*
D68.8
ICD-10 Finland
Other specified coagulation defects
14.6
6.4
10
7
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
6.4
27
92
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.7
6.4
35
138
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
6.4
20
56
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
6.7
6.4
15
23
E66.01
ICD-10 Finland
Obesity due to excess calories
2.5
6.4
40
169
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.9
6.4
30
109
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.1
6.4
16
27
H02AB07
ATC
prednisone; oral
2.3
6.4
51
241
N02BF02
ATC
pregabalin; oral
3.0
6.4
28
98
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
11.3
6.3
11
10
M79.6
ICD-10 Finland
Pain in limb
1.8
6.3
150
1032
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.4
6.3
9
5
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
18.4
6.3
9
5
J01DB01
ATC
cefalexin; oral
2.0
6.3
305
2571
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
+∞
6.3
6
*
D73.0
ICD-10 Finland
Hyposplenism
+∞
6.3
6
*
TGC00
NOMESCO Finland
Bronchial lavation
5.2
6.3
18
36
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
6.2
74
409
C08CA01
ATC
amlodipine; oral
1.8
6.2
134
896
A10AE05
ATC
insulin detemir; parenteral
2.9
6.1
28
100
R06.2
ICD-10 Finland
Wheezing
3.3
6.1
23
73
R4110
NOMESCO Finland
Physiotherapy
1.8
6.1
107
671
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.8
6.1
106
663
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
12.8
6.1
10
8
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
12.8
6.1
10
8
B02.9
ICD-10 Finland
Zoster without complication
2.9
6.1
29
106
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
8.8
6.1
12
14
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.7
6.1
16
29
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
6.0
28
101
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
6.0
84
490
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
205
344
11.80
133.21
8.9
4.9
248.80
263.12
u/l
0.36
200
332
81
60
16.90
89.75
5.2
6.2
2850.20
108.00
iu/ml
—
5
8
129
201
9.21
85.28
2.2
2.0
1.25
1.29
g/l
0.07
121
187
145
274
7.95
80.32
5.7
2.6
78.21
69.30
e9/l
1.61
111
196
99
121
10.72
79.07
2.3
2.3
1.26
1.46
g/l
0.96
83
108
77
66
14.39
78.09
2.2
1.7
—
—
—
0
0
135
273
7.13
69.08
3.3
2.0
0.21
0.22
g/l
1.12
130
256
165
435
5.95
63.17
3.8
2.4
21.27
22.97
%
0.76
158
415
134
302
6.32
60.61
8.3
2.5
8.36
7.65
umol/l
0.15
121
267
300
1414
6.38
55.04
17.1
6.2
13.98
12.16
umol/l
0.70
295
1342
168
500
5.24
54.69
3.9
2.4
11.84
13.25
umol/l
1.67
159
475
162
468
5.30
54.67
3.8
2.4
2.36
2.32
g/l
0.38
153
444
71
99
8.59
50.10
2.9
4.6
28.38
36.16
mg/l
0.77
60
85
70
99
8.45
48.76
3.0
4.6
49.48
103.74
mg/l
0.43
59
85
68
93
8.69
48.71
2.7
4.4
1.59
2.48
ratio
0.46
36
47
270
1280
4.86
45.88
11.0
4.5
36.19
36.09
g/l
0.10
263
1191
199
767
4.36
44.62
4.9
2.9
343.97
354.19
umol/l
0.70
193
692
55
71
8.89
41.08
1.5
1.2
—
—
—
0
0
53
67
9.03
40.23
1.6
1.1
266.06
260.88
u/ml
0.03
33
35
50
61
9.29
38.99
2.0
1.5
142.40
134.19
au/ml
0.15
20
16
310
1759
5.19
38.38
22.1
9.8
4.02
4.02
e9/l
0.00
284
1510
126
397
4.26
36.11
12.0
5.6
1.08
1.08
mmol/l
0.05
126
376
174
697
3.77
35.12
2.1
1.5
2.10
2.32
g/l
0.75
134
414
271
1477
3.93
33.42
15.3
6.9
1.21
1.21
mmol/l
0.26
249
1278
133
466
3.86
32.38
2.4
1.8
—
—
—
0
0
76
174
5.21
32.32
2.3
1.7
—
—
—
0
0
209
993
3.46
31.42
7.0
2.9
36.08
31.64
u/l
0.93
197
935
170
748
3.31
28.33
4.6
2.2
47.87
71.86
u/l
2.13
161
690
93
279
4.09
27.85
12.4
6.5
10.49
9.92
mmol/l
0.27
93
265
118
434
3.50
25.99
1.8
1.7
1274.26
1148.32
nmol/l
0.50
101
338
31
34
9.84
25.96
1.6
1.1
—
—
—
0
0
234
1292
3.12
25.52
16.6
13.1
1.27
1.25
inr
0.30
202
1059
91
296
3.73
24.02
9.0
4.0
0.98
1.23
mmol/l
0.30
78
256
53
116
5.15
23.46
1.3
1.4
—
—
—
0
0
144
631
3.07
23.33
3.5
1.6
2.13
1.21
mg/l
1.10
123
487
99
355
3.42
22.37
2.4
1.7
—
—
—
0
0
74
219
3.96
22.28
3.8
1.9
31.60
60.06
u/l
0.76
62
182
246
1469
2.92
21.99
6.0
2.9
191.56
121.00
ug/l
1.68
240
1372
183
937
2.84
21.97
5.9
3.1
55.36
134.63
e6/l
0.46
154
705
320
2254
3.70
20.58
22.5
7.5
95.61
78.53
u/l
5.05
313
2115
32
21
16.53
20.13
2.4
3.0
—
—
—
0
0
138
634
2.85
20.00
4.5
2.4
5.01
5.07
e6/l
0.02
129
576
91
332
3.29
19.80
2.6
1.7
—
—
—
0
0
44
97
5.00
19.22
1.9
1.5
1.17
1.20
g/l
0.18
44
92
37
70
5.75
19.13
1.9
1.5
—
—
—
0
0
36
67
5.83
18.93
1.6
1.2
—
—
—
0
0
38
76
5.45
18.51
1.9
1.6
—
—
—
0
0
26
13
21.37
18.00
2.5
2.8
1779.92
913.69
u/ml
1.05
26
13
315
2269
3.30
17.99
8.2
4.0
13.08
11.38
mm/h
1.25
308
2097
41
91
4.93
17.74
2.0
2.9
—
—
—
0
0
27
40
7.19
17.65
1.3
1.0
—
—
—
0
0
150
760
2.61
17.51
1.5
1.3
0.70
1.56
u/ml
1.18
36
200
147
738
2.62
17.48
4.6
2.1
—
—
—
0
0
46
115
4.41
17.21
9.8
3.2
1.53
1.43
mg/l
0.38
46
105
157
819
2.57
17.18
6.0
2.9
0.56
0.34
e6/l
0.30
123
592
99
410
2.91
17.08
12.4
7.4
104.08
104.69
mmol/l
0.59
99
410
66
216
3.49
16.92
7.1
4.2
118.49
84.11
ng/l
0.55
61
195
29
24
12.98
16.63
2.4
2.3
581.36
545.26
e6/l
0.09
22
19
27
19
15.20
16.58
4.5
2.1
94.85
103.26
%
0.35
27
19
41
97
4.62
16.42
1.6
1.5
0.00
0.04
iu/ml
—
7
19
56
168
3.74
16.33
2.2
1.5
—
—
—
0
0
226
1417
2.47
16.33
5.3
2.6
—
—
estimate
—
0
0
28
47
6.35
16.29
1.8
1.8
—
—
—
0
0
24
13
19.62
16.22
2.8
1.9
—
—
—
0
0
24
13
19.62
16.22
2.8
1.9
—
—
—
0
0
26
41
6.73
16.04
1.5
1.2
—
—
—
0
0
230
1461
2.46
16.03
23.9
10.2
0.00
0.00
e9/l
0.53
197
1183
62
202
3.47
15.96
12.3
4.3
23.93
23.74
mmol/l
0.27
62
202
157
846
2.46
15.74
4.7
3.2
1437.98
1171.54
ng/l
0.38
136
736
261
1766
2.54
15.68
12.2
4.9
7.34
6.67
mmol/l
3.86
256
1654
92
382
2.86
15.68
2.8
2.7
113.32
120.35
ug/g
0.09
80
297
26
43
6.42
15.33
5.0
2.3
31.69
33.12
pg
0.73
26
43
23
35
6.93
14.64
2.0
1.5
—
—
—
0
0
27
26
11.09
14.47
1.7
1.3
—
—
—
0
0
204
1304
2.22
13.02
2.7
2.0
91.89
96.19
pmol/l
0.59
141
692
100
473
2.51
12.92
4.8
2.8
3.38
1.64
e6/l
1.10
55
233
149
846
2.25
12.66
2.1
1.6
18.49
19.75
nmol/l
0.49
141
713
42
123
3.72
12.61
2.2
1.8
4.12
10.76
iu/ml
—
10
28
47
150
3.44
12.41
5.8
2.7
0.67
0.62
%
0.29
47
150
104
512
2.42
12.26
4.4
2.7
1.23
0.82
e6/l
0.72
59
270
27
58
4.94
12.08
1.2
1.4
—
—
—
0
0
58
215
3.00
11.96
2.7
2.1
57.85
66.75
ml/min/173m2
0.75
27
85
21
36
6.12
11.92
2.0
1.5
—
—
—
0
0
47
154
3.34
11.90
5.8
2.7
2.02
1.17
%
2.72
47
154
22
22
10.54
11.65
2.3
2.0
0.48
0.60
e9/l
0.62
22
22
29
70
4.40
11.28
1.6
1.3
—
—
—
0
0
24
30
8.46
11.26
1.5
1.2
—
—
—
0
0
27
62
4.61
11.17
1.4
1.3
307.05
262.27
ug/g
0.40
20
35
25
54
4.89
11.11
1.6
1.3
—
—
—
0
0
266
1959
2.20
11.07
6.3
3.8
1680.40
1282.50
e6/l
—
10
30
51
186
3.01
10.79
7.1
3.6
1.56
1.77
mmol/l
0.13
38
135
83
389
2.45
10.77
2.4
1.8
1.55
1.37
%
1.39
77
345
167
1041
2.08
10.77
4.5
3.3
21.52
41.23
ng/l
4.07
123
741
61
246
2.76
10.75
2.7
4.7
6.26
37.20
ug/l
0.59
47
206
43
146
3.19
10.26
2.2
1.6
0.15
0.31
mg/l
1.61
13
70
55
217
2.80
10.08
7.6
3.5
5.05
5.13
kpa
0.30
55
206
58
236
2.72
10.02
21.8
8.9
24.06
24.77
mmol/l
0.68
58
236
52
200
2.85
9.99
1.6
1.2
189.04
383.04
u/ml
0.57
47
182
9
0
+∞
9.41
1.1
0.0
—
—
—
0
0
28
76
3.90
9.34
1.7
1.7
—
—
—
0
0
21
46
4.77
9.17
7.9
4.4
4.97
5.01
kpa
0.07
21
46
173
1140
1.95
9.15
5.1
3.5
7.18
8.10
mmol/l
2.10
159
971
13
7
19.17
8.99
2.9
2.0
1.31
1.25
ratio
—
13
7
155
992
1.95
8.86
5.6
3.3
2.34
2.36
mmol/l
1.13
149
908
276
2145
2.05
8.84
7.9
2.9
74.66
43.98
u/l
6.48
266
2022
20
44
4.74
8.69
8.4
2.0
10.47
7.96
pmol/l
0.59
20
44
20
29
7.22
8.66
1.0
1.0
—
—
—
0
0
13
8
16.76
8.61
3.8
1.4
0.60
0.59
mmol/l
—
13
8
225
1643
1.91
8.50
5.7
3.4
0.00
1.09
estimate
0.50
45
279
70
337
2.32
8.44
15.2
8.7
0.12
0.52
mmol/l
0.30
58
296
30
92
3.46
8.40
3.9
2.4
23.52
24.55
mmol/l
0.61
30
92
31
98
3.36
8.28
2.1
1.9
—
—
—
0
0
223
1632
1.89
8.28
5.6
3.4
0.00
0.00
estimate
-0.00
48
310
221
1615
1.88
8.22
5.6
3.3
0.00
0.00
estimate
-0.00
48
308
14
12
12.06
8.14
1.1
1.0
—
—
—
0
0
159
1049
1.89
8.13
6.4
4.3
30.74
8.38
mg/mmol
1.05
108
678
27
79
3.60
8.10
1.8
1.3
—
—
—
0
0
27
79
3.60
8.10
1.7
1.3
19.27
2.37
u/ml
—
7
14
25
71
3.70
7.83
1.2
1.2
—
—
—
0
0
139
887
1.90
7.81
2.3
1.9
555.82
256.32
u/l
0.29
133
838
62
293
2.33
7.77
4.2
3.0
—
—
—
0
0
100
572
2.02
7.74
2.1
1.6
457.59
24426299.45
pmol/l
0.50
91
479
19
45
4.39
7.56
4.5
3.0
15.75
15.92
%
0.07
19
45
49
213
2.49
7.37
19.5
10.5
0.63
0.64
%
0.08
49
213
14
15
9.64
7.34
1.1
1.8
16.64
10.87
u/l
2.02
14
15
14
15
9.64
7.34
4.9
3.0
1.18
1.13
%
0.03
14
15
14
15
9.64
7.34
1.0
1.1
—
—
—
0
0
7
0
+∞
7.31
3.9
0.0
—
—
—
0
0
18
42
4.45
7.29
1.6
1.3
91.78
150.81
pmol/l
0.29
18
42
11
7
16.12
7.27
5.5
2.3
197.64
226.43
u/l
—
11
7
51
228
2.43
7.22
3.3
2.4
0.34
0.40
e6/l
0.16
51
219
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
92
3.21
7.05
8.0
2.8
0.30
0.33
iu/ml
0.30
15
44
17
27
6.54
7.02
1.9
2.1
—
—
—
0
0
28
95
3.10
6.69
2.1
1.8
—
—
—
0
0
37
148
2.66
6.58
1.9
1.3
—
—
—
0
0
18
46
4.06
6.51
6.6
5.7
11.30
10.43
mg/l
0.30
18
40
94
558
1.91
6.42
1.5
1.3
27.44
32.61
iu/ml
0.17
25
157
20
56
3.71
6.40
1.6
1.2
—
—
—
0
0
20
56
3.71
6.40
1.6
1.2
—
—
—
0
0
6
0
+∞
6.26
5.5
0.0
88.17
—
ug/min
—
6
0
23
73
3.29
6.12
2.6
2.5
390.21
67.62
ug/min
1.08
14
37
10
8
12.79
6.11
1.2
3.0
280.70
122.75
%
—
10
8
9
6
15.31
5.93
1.0
1.2
—
—
—
0
0
26
92
2.96
5.80
2.4
1.6
—
—
—
0
0
15
27
5.74
5.74
1.2
1.4
—
—
—
0
0
17
36
4.89
5.68
2.9
2.1
1.84
1.60
mmol/l
0.49
17
36
131
889
1.72
5.66
5.3
3.5
0.02
0.01
estimate
0.15
43
293
89
539
1.85
5.65
4.5
3.6
492.16
679.64
ng/l
0.22
64
432
23
77
3.12
5.63
1.3
1.2
—
—
—
0
0
16
32
5.17
5.63
1.9
2.0
—
—
—
0
0
87
525
1.85
5.58
1.4
1.3
3.52
8.37
u/ml
1.00
26
189
16
33
5.01
5.49
1.1
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
11
14
8.05
5.38
1.2
2.1
233.36
136.43
%
1.95
11
14
16
34
4.87
5.36
1.6
1.1
—
—
—
0
0
9
9
10.21
5.05
1.2
1.0
—
—
—
0
0
16
37
4.47
4.99
1.2
1.1
—
—
—
0
0
14
28
5.15
4.99
3.9
1.5
—
—
—
0
0
8
7
11.64
4.80
1.1
1.1
85.88
84.14
%
—
8
7
284
2415
1.70
4.77
5.2
4.1
14.81
14.76
pmol/l
0.12
269
2208
7
5
14.22
4.59
1.1
1.2
—
—
—
0
0
24
93
2.69
4.57
3.1
2.1
43.02
7346.32
u/l
—
5
46
11
19
5.93
4.47
1.4
1.2
109.73
110.84
pmol/l
0.02
11
19
13
28
4.77
4.41
1.2
1.2
—
—
—
0
0
161
1211
1.57
4.39
5.3
3.2
0.07
0.01
estimate
0.42
45
262
12
24
5.13
4.35
1.4
1.7
—
—
—
0
0
12
24
5.13
4.35
1.4
1.7
—
—
—
0
0
12
24
5.13
4.35
1.4
1.7
—
—
—
0
0
37
185
2.11
4.04
1.6
1.3
53.20
39.35
au/ml
—
5
17
7
7
10.16
4.02
1.7
1.6
—
—
—
0
0
16
53
3.11
4.01
1.1
1.2
—
—
—
0
0
12
27
4.55
3.97
2.8
2.1
89.69
86.97
%
0.73
12
27
345
3160
2.02
3.85
40.3
12.6
20.83
23.72
mg/l
1.10
317
2465
14
44
3.27
3.81
2.0
1.2
4.78
4.40
u/ml
—
9
20
7
8
8.89
3.78
1.7
3.3
3.71
6.74
ug/l
—
7
8
16
55
2.99
3.78
1.7
1.3
—
—
—
0
0
10
20
5.10
3.71
2.4
1.5
—
—
—
0
0
12
30
4.10
3.62
2.6
1.5
—
—
—
0
0
12
31
3.96
3.52
2.6
1.5
—
—
—
0
0
6
6
10.13
3.51
1.7
1.0
95.67
99.50
%
—
6
6
6
6
10.13
3.51
1.0
1.0
—
—
—
0
0
19
76
2.58
3.43
1.4
1.2
—
—
—
0
0
19
76
2.58
3.43
1.4
1.2
—
—
—
0
0
7
10
7.11
3.37
1.4
2.0
—
—
—
0
0
7
10
7.11
3.37
1.4
2.0
—
—
—
0
0
7
10
7.11
3.37
1.4
2.0
—
—
—
0
0
7
10
7.11
3.37
1.4
2.0
—
—
—
0
0
118
876
1.50
3.22
5.3
2.8
0.06
0.10
estimate
0.12
47
247
11
29
3.87
3.21
2.6
1.6
—
—
—
0
0
8
15
5.42
3.20
1.3
4.1
57.75
85.40
nmol/l
—
8
15
11
30
3.74
3.11
2.6
1.5
—
—
—
0
0
11
30
3.74
3.11
2.6
1.5
—
—
—
0
0
8
16
5.08
3.06
1.0
1.5
13.88
9.62
u/l
—
8
16
6
8
7.60
3.06
1.3
2.0
—
—
—
0
0
6
8
7.60
3.06
1.3
2.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
12
5.92
3.03
1.6
1.2
88.71
117.25
%
—
7
12
11
31
3.62
3.01
5.1
4.1
—
—
—
0
0
11
31
3.62
3.01
2.7
1.5
—
—
—
0
0
344
3193
1.84
3.01
44.3
15.4
3.99
3.98
mmol/l
0.19
339
3102
9
21
4.36
3.01
1.4
1.2
—
—
—
0
0
19
82
2.39
2.96
4.1
2.5
0.71
2.17
index
1.01
14
42
9
22
4.16
2.90
1.4
1.2
—
—
—
0
0
9
22
4.16
2.90
1.4
1.2
—
—
—
0
0
9
22
4.16
2.90
1.3
1.2
—
—
—
0
0
319
2910
1.61
2.89
6.6
5.0
2.01
1.91
mu/l
0.79
305
2687
6
9
6.75
2.87
1.3
1.9
—
—
—
0
0
12
38
3.23
2.87
1.2
1.2
—
—
—
0
0
9
23
3.98
2.79
1.4
1.2
—
—
—
0
0
5
6
8.42
2.75
9.0
5.2
4.92
6.27
mmol/l
—
5
6
18
79
2.34
2.72
4.3
3.5
3.82
3.96
mmol/l
0.75
18
79
10
29
3.51
2.71
1.4
1.2
—
—
—
0
0
12
43
2.85
2.67
1.8
1.3
—
—
—
0
0
7
15
4.73
2.61
2.0
1.4
—
—
—
0
0
5
8
6.31
2.38
1.2
1.1
—
—
—
0
0
85
626
1.46
2.35
1.9
1.6
—
—
—
0
0
6
13
4.67
2.28
2.7
1.5
80.63
107.67
ng/l
—
6
13
325
3018
1.54
2.27
35.7
13.1
82.02
83.15
ml/min/173m2
0.36
312
2735
7
18
3.94
2.26
1.0
1.1
297.71
224.67
iu/ml
—
7
18
8
24
3.38
2.19
1.0
1.5
172.50
690.74
u/l
—
8
24
14
62
2.31
2.10
1.4
1.2
64.89
30.52
e6/l
—
9
48
14
62
2.31
2.10
1.6
1.6
—
—
—
0
0
5
10
5.05
2.07
1.2
1.1
—
—
—
0
0
6
15
4.05
2.04
1.0
1.1
1419.67
1407.40
miu/ml
—
6
15
6
15
4.05
2.04
2.2
1.4
—
—
—
0
0
6
15
4.05
2.04
1.2
2.5
0.67
1.00
index
—
6
15
8
26
3.12
2.02
6.4
2.3
106.63
105.73
mmol/l
—
8
26
8
26
3.12
2.02
6.4
2.3
1.20
1.20
mmol/l
—
8
26
37
234
1.64
2.02
1.6
1.4
—
—
—
0
0
6
16
3.79
1.94
2.0
1.3
—
—
—
0
0
6
16
3.79
1.94
2.0
1.3
—
—
—
0
0
92
715
1.38
1.87
3.9
3.5
1.02
1.02
kg/l
0.24
61
465
6
17
3.57
1.84
1.5
1.1
—
—
—
0
0
20
109
1.88
1.81
1.5
1.3
178.90
260.97
miu/ml
—
8
54
7
23
3.08
1.80
1.9
1.1
—
—
—
0
0
7
23
3.08
1.80
1.9
1.1
—
—
—
0
0
235
2102
1.31
1.78
3.7
3.0
—
—
—
0
0
6
18
3.37
1.75
2.2
1.3
—
—
—
0
0
16
83
1.97
1.67
1.7
1.3
—
—
—
0
0
5
14
3.60
1.62
1.4
1.1
—
—
—
0
0
7
27
2.62
1.52
1.7
1.5
—
—
—
0
0
6
21
2.89
1.51
1.2
1.2
—
—
—
0
0
6
21
2.89
1.51
1.0
6.7
—
39.80
—
0
5
9
38
2.40
1.46
1.1
1.1
—
—
—
0
0
31
211
1.51
1.30
1.4
1.2
83.00
147.22
u/ml
0.63
12
86
8
35
2.31
1.27
1.0
1.2
—
—
—
0
0
13
72
1.83
1.16
1.5
1.2
—
—
—
0
0
22
146
1.54
1.06
1.5
1.4
—
—
—
0
0
32
232
1.41
1.01
1.9
2.1
—
—
—
0
0
313
2996
1.26
0.92
6.2
4.9
6.39
5.94
mmol/l
4.93
301
2757
6
29
2.09
0.89
1.2
1.0
—
—
—
0
0
6
29
2.09
0.89
1.2
1.0
—
—
—
0
0
14
87
1.63
0.89
2.4
2.2
1.93
6.06
iu/l
—
5
36
10
57
1.77
0.84
1.5
1.6
—
—
—
0
0
310
2974
1.23
0.83
5.0
4.1
1.49
1.28
mmol/l
3.36
298
2772
6
33
1.83
0.79
2.2
2.4
14.17
13.05
%
—
6
33
149
1348
1.17
0.79
2.2
1.9
1.60
1.35
mmol/l
2.23
126
1146
64
755
0.82
0.75
3.5
3.1
0.84
0.76
ug/l
0.29
48
479
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
53
439
1.24
0.71
3.2
2.0
—
—
—
0
0
306
2949
1.20
0.67
9.3
6.1
40.73
39.06
mmol/mol
1.83
294
2783
323
3136
1.20
0.60
5.9
4.9
4.26
4.57
mmol/l
6.74
308
2949
87
973
0.86
0.56
4.0
4.4
23.12
21.84
%
0.31
42
460
9
132
0.67
0.53
1.0
1.1
1.33
1.51
g/l
—
9
132
48
409
1.20
0.52
3.2
1.9
—
—
—
0
0
11
77
1.44
0.46
1.4
1.5
—
—
—
0
0
5
84
0.59
0.46
1.2
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
3.3
—
3.65
—
0
5
46
401
1.17
0.40
1.5
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
325
3183
1.15
0.39
6.5
5.5
2.49
2.69
mmol/l
3.92
314
2985
8
113
0.70
0.37
1.5
1.5
—
—
—
0
0
25
207
1.22
0.37
1.8
1.9
—
—
—
0
0
17
135
1.27
0.36
1.7
1.1
0.87
0.89
g/l
0.12
17
135
318
3127
1.11
0.27
5.7
4.8
1.24
1.42
mmol/l
11.92
301
2927
11
133
0.82
0.19
2.9
1.8
31.00
39.30
nmol/l
1.54
11
127
10
115
0.87
0.11
1.7
2.0
—
—
—
0
0
36
339
1.07
0.10
8.2
6.0
—
—
—
0
0
123
1202
1.03
0.09
5.1
5.2
1.93
2.33
ug/l
0.56
113
1073
17
155
1.10
0.09
1.0
1.0
—
—
—
0
0
10
106
0.94
0.01
3.2
1.8
157.00
223.69
pmol/l
—
10
97
0
7
0.00
-0.00
0.0
1.0
—
26.30
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
6.89
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
12.57
—
0
5
7
77
0.91
-0.00
1.9
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.4
—
9.81
—
0
9
0
5
0.00
-0.00
0.0
7.2
—
10.68
—
0
5
0
9
0.00
-0.00
0.0
2.4
—
4.72
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
56.20
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED – Hepatomegaly and splenomegaly, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).